Closed Loop Opportunity Tandem is actively pursuing fully closed loop automated insulin delivery systems, signaling a growing demand for integrated diabetes management solutions. Sales teams can prioritize partnerships or channel opportunities with glucose sensor ecosystems and data integration vendors to expand the addressable market and secure larger system deals.

Software & Apps Recent app launches and software issues indicate a strong need for robust software stability and mobile ecosystem enhancements. Focus on selling software maintenance, updates, and cloud-based telemetry services to support implantable devices, data analytics, and patient engagement features.

Sensor Integration Integration with FreeStyle Libre 3 Plus Sensor suggests a strategy to co-sell with leading continuous glucose monitoring (CGM) brands. Explore cross-sell or OEM partnership opportunities to embed Tandem platforms with popular sensors, expanding adoption in clinics and patient homes.

Regulatory & Security ISO 9001 and enterprise-grade tech stack imply emphasis on quality, compliance, and secure deployments. Market Tandem’s compliance, safety, and data-security capabilities to larger medical device customers seeking validated, auditable insulin delivery solutions.

Board & Funding Signals Board enhancements and ongoing investor activity alongside a sizable revenue base point to continued growth and potential equity-based incentives. Target strategic investors and healthcare distributors, offering scalable deployment programs and long-term commitments to accelerate market expansion.